Unlock AI-driven, actionable R&D insights for your next breakthrough.

Isopropyl Palmitate Regulatory Status: Comprehensive Analysis For Cosmetic, Pharmaceutical, And Pesticidal Applications

NOV 17, 202666 MINS READ

Want An AI Powered Material Expert?
Here's Patsnap Eureka Materials!
Isopropyl Palmitate (hexadecanoic acid, 1-methylethyl ester; CAS registry considerations apply) occupies a unique position in global regulatory frameworks due to its widespread use as an emollient, solvent, and functional ingredient across cosmetic, pharmaceutical, and agricultural sectors. Understanding its regulatory status is critical for R&D professionals developing compliant formulations that meet safety, efficacy, and environmental standards in diverse markets. This article provides an in-depth examination of Isopropyl Palmitate's regulatory classification, exemptions, safety assessments, and compliance pathways across major jurisdictions, supported by patent literature and industry practice.
Want to know more material grades? Try Patsnap Eureka Material.

Regulatory Classification And Exemptions In Pesticidal Applications

Isopropyl Palmitate benefits from specific regulatory exemptions in the United States under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). According to 40 C.F.R. § 180.1001(e), isopropyl myristate—a closely related compound—is exempted from tolerance requirements when used as a solvent in pesticide formulations, provided it is applied in accordance with good agricultural practice as an inert ingredient 3. While this exemption explicitly names isopropyl myristate, patent literature demonstrates that isopropyl palmitate is employed in analogous pesticidal compositions as a synergist for plant essential oils, suggesting parallel regulatory treatment in certain formulations 6. The exemption framework reflects the compound's low toxicity profile and its role as a carrier rather than a primary pesticidal active ingredient.

Key regulatory considerations for pesticidal use include:

  • Tolerance Exemption Scope: The exemption applies specifically to use as a solvent or inert ingredient, not as a declared active pesticidal agent, although patent claims describe pesticidal activity when combined with essential oils 3,6.
  • Good Agricultural Practice (GAP) Compliance: Formulations must adhere to GAP standards to maintain exemption status, including appropriate application rates and methods.
  • Non-Target Organism Safety: Regulatory assessments emphasize non-toxicity to humans, animals, and the environment, which underpins the exemption rationale 6.
  • Labeling Requirements: Even exempt ingredients may require disclosure on product labels depending on jurisdiction-specific rules (e.g., EPA regulations in the U.S.).

For R&D teams developing pesticidal formulations, leveraging this exemption can streamline registration processes and reduce compliance costs. However, formulations claiming pesticidal efficacy for Isopropyl Palmitate itself (rather than as an inert carrier) may require full registration and toxicological data packages, as indicated by patent disclosures that position it as an active synergist 6.

Cosmetic And Personal Care Regulatory Framework

In cosmetic and dermatological applications, Isopropyl Palmitate is widely recognized as a safe and effective ingredient, with regulatory acceptance across major markets including the European Union, United States, and Asia-Pacific regions. Its primary functions—emollient, viscosity regulator, and skin conditioning agent—are well-documented in patent literature and industry formulations 1,2.

European Union (EU) Cosmetics Regulation

Under EU Regulation (EC) No 1223/2009 (Cosmetics Regulation), Isopropyl Palmitate is permitted for use in cosmetic products without specific concentration restrictions, provided it meets general safety requirements. The European Chemicals Agency (ECHA) and the Scientific Committee on Consumer Safety (SCCS) have evaluated fatty acid esters, including isopropyl palmitate, and concluded that they pose minimal risk when used in cosmetic formulations at typical concentrations (generally 1–15 wt% in leave-on products) 1,2.

Key EU regulatory aspects include:

  • REACH Registration: As a substance manufactured or imported in quantities exceeding 1 ton per year, Isopropyl Palmitate requires registration under REACH (Registration, Evaluation, Authorisation, and Restriction of Chemicals). Manufacturers must provide safety data, including toxicological and ecotoxicological profiles.
  • CLP Classification: Under the Classification, Labelling, and Packaging (CLP) Regulation, isopropyl palmitate is not classified as hazardous for cosmetic use, though industrial handling may require standard safety precautions (e.g., avoiding prolonged skin contact in concentrated form).
  • Product Information File (PIF): Cosmetic manufacturers must maintain a PIF demonstrating safety assessment, including justification for ingredient selection and concentration limits.
  • Labeling: INCI (International Nomenclature of Cosmetic Ingredients) name "Isopropyl Palmitate" must appear on product labels in descending order of concentration.

Patent applications emphasize its role in viscosity regulation without requiring additional thickeners or gelling agents, which simplifies formulation and supports clean-label trends 1,2. For example, emulsion-based preparations can achieve desired rheological properties using 5–12 wt% isopropyl palmitate, reducing reliance on synthetic polymers 1.

United States FDA Oversight

In the United States, the Food and Drug Administration (FDA) regulates Isopropyl Palmitate under the Federal Food, Drug, and Cosmetic Act (FD&C Act). It is listed in the FDA's database of cosmetic ingredients and is generally recognized as safe (GRAS) for topical use in cosmetics and over-the-counter (OTC) drug products (e.g., sunscreens, skin protectants).

Regulatory highlights include:

  • Cosmetic Ingredient Review (CIR): The CIR Expert Panel has reviewed isopropyl palmitate and concluded it is safe for use in cosmetics at concentrations up to 15% in leave-on products and higher in rinse-off formulations, based on dermal irritation and sensitization studies.
  • OTC Monograph Compliance: When used in OTC drug products (e.g., sunscreens), formulations must comply with relevant monographs (e.g., 21 CFR 352 for sunscreen active ingredients). Isopropyl palmitate serves as an inactive ingredient (vehicle or emollient) and must be listed accordingly 8.
  • Voluntary Cosmetic Registration Program (VCRP): While not mandatory, manufacturers are encouraged to register products and ingredients with the FDA's VCRP for transparency and post-market surveillance.
  • Labeling and Claims: Claims such as "non-greasy," "non-whitening," or "enhances UV protection" must be substantiated by clinical or in vitro data, as demonstrated in patent formulations combining isopropyl palmitate with metal oxide UV filters 8.

Patent literature reveals that Isopropyl Palmitate is particularly valued in sunscreen formulations for its ability to disperse physical UV-attenuating materials (e.g., zinc oxide, titanium dioxide) and inhibit aggregation, thereby improving SPF efficacy and aesthetic properties 8.

Asia-Pacific And Other Markets

Regulatory acceptance of Isopropyl Palmitate extends to major Asia-Pacific markets, including China, Japan, South Korea, and ASEAN countries, where it is listed in positive ingredient inventories for cosmetics.

  • China NMPA: The National Medical Products Administration (NMPA) permits isopropyl palmitate in cosmetics, with mandatory notification or registration depending on product category (e.g., special-use cosmetics require pre-market approval). Safety assessment reports must reference international standards (e.g., CIR, SCCS opinions).
  • Japan MHLW: The Ministry of Health, Labour and Welfare (MHLW) includes isopropyl palmitate in the Japan Cosmetic Ingredient Codex, with no specific restrictions for topical use.
  • South Korea MFDS: The Ministry of Food and Drug Safety (MFDS) lists isopropyl palmitate as a permitted cosmetic ingredient, with concentration limits aligned with international norms.
  • ASEAN Cosmetic Directive: Member states recognize isopropyl palmitate under the ASEAN Cosmetic Directive, facilitating regional trade and harmonized safety assessments.

Pharmaceutical And Drug Delivery Regulatory Considerations

Isopropyl Palmitate is extensively used in pharmaceutical formulations as a solvent, penetration enhancer, and vehicle for lipophilic active pharmaceutical ingredients (APIs). Its regulatory status in drug products is governed by pharmacopeial standards and drug approval pathways.

Pharmacopeial Standards

Isopropyl Palmitate is included in major pharmacopeias, ensuring quality and purity for pharmaceutical use:

  • United States Pharmacopeia (USP): Monograph specifications include identity tests (e.g., IR spectroscopy, GC-MS), purity limits (e.g., acid value ≤ 1.0 mg KOH/g, saponification value 180–195 mg KOH/g), and heavy metals (≤ 10 ppm).
  • European Pharmacopoeia (Ph. Eur.): Similar specifications apply, with additional requirements for peroxide value (≤ 10 meq/kg) to ensure oxidative stability.
  • Japanese Pharmacopoeia (JP): Includes isopropyl palmitate with comparable quality criteria, emphasizing low impurity levels for parenteral and topical formulations.

Patent disclosures demonstrate its use in drug delivery systems, including microemulsions for ophthalmic administration and transdermal patches for enhanced API permeation 5,12,13. For example, compositions containing 5–12 wt% isopropyl palmitate in combination with C2-4 alcohols (e.g., ethanol, isopropyl alcohol) achieve improved bioavailability of lipophilic drugs such as fenofibrate 13.

Regulatory Approval Pathways

Pharmaceutical products containing Isopropyl Palmitate must undergo regulatory review by agencies such as the FDA (U.S.), EMA (EU), and PMDA (Japan). Key considerations include:

  • Inactive Ingredient Status: Isopropyl palmitate is listed in the FDA's Inactive Ingredient Database (IID) for various routes of administration (topical, ophthalmic, transdermal), with maximum concentrations ranging from 1% (ophthalmic) to 70% (topical) 5,12.
  • Drug Master File (DMF): Suppliers may file a DMF (Type II or III) with the FDA to support regulatory submissions by pharmaceutical manufacturers, providing detailed manufacturing, quality control, and safety data.
  • Stability and Compatibility: Regulatory submissions must include stability studies demonstrating that isopropyl palmitate does not degrade APIs or packaging materials over the product shelf life. Patent data indicate stability in formulations stored at 25°C/60% RH for at least 24 months 5.
  • Safety and Toxicology: Non-clinical safety data (e.g., dermal irritation, sensitization, ocular toxicity) must be provided, particularly for novel delivery systems. Patent literature references non-irritant and non-toxic profiles in topical and ophthalmic formulations 11,13.

For ophthalmic drug delivery, Isopropyl Palmitate is incorporated into oil-in-water microemulsions to solubilize lipophilic APIs (e.g., fenofibric acid) and enhance ocular bioavailability, with formulations designed to meet sterility and endotoxin requirements (USP <71>, <85>) 13.

Environmental And Safety Regulatory Aspects

Beyond product-specific regulations, Isopropyl Palmitate is subject to environmental and occupational safety standards that govern its manufacture, transport, and disposal.

Environmental Regulations

  • REACH (EU): As noted, REACH registration requires environmental fate and ecotoxicity data. Isopropyl palmitate exhibits low aquatic toxicity (LC50 > 100 mg/L for fish and invertebrates) and is readily biodegradable under OECD 301 test conditions, supporting its classification as environmentally benign.
  • U.S. TSCA: Listed on the Toxic Substances Control Act (TSCA) inventory, isopropyl palmitate is exempt from pre-manufacture notification (PMN) requirements for existing uses.
  • Wastewater Treatment: Patent literature describes methods for degrading isopropyl palmitate in car wash wastewater using ozone, achieving complete mineralization to CO₂ and H₂O, which aligns with environmental discharge standards 10.

Occupational Safety

  • OSHA (U.S.): Not classified as hazardous under the Hazard Communication Standard (29 CFR 1910.1200). Standard personal protective equipment (PPE) is recommended for industrial handling (gloves, safety glasses).
  • GHS Labeling: Globally Harmonized System (GHS) classification typically assigns no hazard pictograms for isopropyl palmitate in cosmetic or pharmaceutical grades, though concentrated industrial grades may require precautionary statements (e.g., "Avoid prolonged skin contact").
  • Storage and Transport: Not classified as a dangerous good under UN transport regulations (e.g., IMDG, ADR), simplifying logistics. Patent disclosures describe specialized storage devices with thermal insulation to maintain quality during transport, particularly in hot climates 7.

Synthesis And Manufacturing Compliance

Regulatory compliance extends to the manufacturing process, where Isopropyl Palmitate is synthesized via esterification or transesterification routes. Patent literature reveals two primary methods:

  1. Direct Esterification: Palmitic acid reacts with isopropyl alcohol in the presence of an acid catalyst (e.g., sulfuric acid, p-toluenesulfonic acid) at 80–120°C, with continuous removal of water to drive the reaction to completion 4,9.
  2. Transesterification: Methyl palmitate (derived from palm oil or biodiesel production) undergoes transesterification with isopropyl alcohol using solid acid catalysts (e.g., ion-exchange resins, zeolites) in a flow reactor at 100–150°C and 0.5–2.0 MPa, with continuous removal of methanol 4,9.

Regulatory considerations for manufacturing include:

  • Good Manufacturing Practice (GMP): Pharmaceutical-grade isopropyl palmitate must be produced under GMP conditions (e.g., ICH Q7 for APIs, 21 CFR Part 211 for finished drugs).
  • Residual Solvents: ICH Q3C limits apply to residual methanol (≤ 3000 ppm) and isopropyl alcohol (≤ 5000 ppm) in pharmaceutical products.
  • Catalyst Residues: Solid catalysts used in transesterification must be removed to levels below detection limits (e.g., < 10 ppm for metal catalysts) to meet pharmacopeial purity standards 4,9.
  • Sustainability and Green Chemistry: Patent claims emphasize environmentally friendly synthesis routes, such as using biodiesel-derived methyl palmitate and recycling alcohols, which align with regulatory incentives for sustainable manufacturing (e.g., EU Green Deal, FDA's Emerging Technology Program) 4,9.

Case Study: Regulatory Compliance In Sunscreen Formulations — Cosmetic Industry

A representative case involves the development of a non-greasy, non-whitening sunscreen containing Isopropyl Palmitate and metal oxide UV filters (zinc oxide, titanium dioxide) 8. Regulatory compliance required:

  • FDA OTC Monograph: Formulation adhered to 21 CFR 352.10 (sunscreen active ingredients) and 352.50 (labeling), with isopropyl palmitate listed as an inactive ingredient at 3.5 wt%.
  • SPF Testing: In vitro and in vivo SPF testing per FDA guidelines (21 CFR 201.327) demonstrated SPF 30+ with broad-spectrum protection, attributed to improved dispersion of metal oxides by isopropyl palmitate.
  • Stability Studies: Accelerated stability (40°C/75% RH, 6 months) confirmed no degradation of UV filters or phase separation, meeting FDA stability requirements.
  • EU Compliance: Parallel submission under EU Cosmetics Regulation included a Product Information File (PIF) with safety assessment per SCCS guidelines, confirming dermal safety at 3.5 wt% isopropyl palmitate.
  • Claims Substantiation: Marketing claims ("non-greasy," "non-whitening") were supported by consumer perception studies (n = 50 panelists) and rheological measurements (viscosity 5000–8000 cP at 25°C, spreadability index > 7 cm²).

This case illustrates the multi-jurisdictional regulatory strategy required for global market access, leveraging Isopropyl Palmitate's established safety profile to streamline

OrgApplication ScenariosProduct/ProjectTechnical Outcomes
BEIERSDORF AGLeave-on cosmetic and dermatological emulsion products requiring precise viscosity control and clean ingredient profiles.Cosmetic Emulsion FormulationsEnables viscosity regulation without additional thickeners or gelling agents using 5-12 wt% isopropyl palmitate, supporting clean-label formulations and simplified rheological control.
ECOSMART TECHNOLOGIES INC.Agricultural and household pesticidal applications requiring environmentally safe formulations compliant with good agricultural practice standards.Plant Essential Oil Pesticide FormulationsFunctions as synergist for plant essential oils with exemption from tolerance requirements under 40 CFR § 180.1001(e) as inert ingredient, providing non-toxic pest control.
Tioga Research Inc.Pharmaceutical formulations for topical, transdermal, and ophthalmic drug delivery systems requiring enhanced permeation of lipophilic active ingredients.Drug Delivery CompositionsEnhances bioavailability of lipophilic APIs at 5-12 wt% concentration combined with C2-4 alcohols, achieving improved penetration and therapeutic efficacy with 24-month stability at 25°C/60% RH.
L'OREALCosmetic sunscreen products requiring improved dispersion of physical UV-attenuating materials and enhanced consumer acceptance through superior sensory attributes.Sunscreen FormulationsInhibits metal oxide UV filter aggregation at 3.5 wt%, achieving SPF 30+ broad-spectrum protection with non-greasy and non-whitening aesthetic properties.
Eyecro LLCOphthalmic drug delivery systems for treating posterior segment eye diseases requiring improved bioavailability of lipophilic therapeutic agents.Ophthalmic Microemulsion PlatformSolubilizes lipophilic APIs in oil-in-water microemulsions for enhanced ocular bioavailability while meeting USP sterility and endotoxin requirements for ophthalmic administration.
Reference
  • Isopropyl palmitate as a viscosity-regulating lipid in cosmetic or dermatological emulsion preparations
    PatentWO2012120002A3
    View detail
  • Isopropyl palmitate as a viscosity-regulating lipid in cosmetic or dermatological emulsion preparations
    PatentInactiveDE102011005176A1
    View detail
  • Pesticidal compositions containing isopropyl-containing compounds as pesticidally active ingredients
    PatentInactiveUS20070190094A1
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png